Proteolix
South San Francisco
About Proteolix
Onyx Pharmaceuticals (NASDAQ: ONXX) is a biopharmaceutical company engaged in the development and commercialization of innovative therapies for improving the lives of people with cancer and other serious diseases.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 10,001+
- Total funding: $142.3M
- Funding stage: M&A
- Last round: Series C (Sep 2008)
- Website: proteolix.com
- Phone: +1 650-266-2600
Industries & Categories
Biopharma, Biotechnology, Health Care, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/proteolix-1769769 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.